Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells

PeerJ

Volumn 2013, Issue 1, 2013, Pages

  Goldberg, Alexander A ^a   Titorenko, Vladimir I ^b   Beach, Adam ^b   Thomas Sanderson, J ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b Dept of Electrical and Computer Engineering   (Canada)

Author keywords

Apoptosis; Bile acids; Cell death; Chemotherapy; Cytotoxicity; Extracellular; In vitro; Lithocholic acid; Mitochondrial membrane permeability; Prostate cancer

Indexed keywords

ANDROGEN; ANDROSTANOLONE; CASPASE 3; CASPASE 8; CASPASE 9; LITHOCHOLIC ACID; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL PERMEABILIZATION; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MITOCHONDRIAL MEMBRANE POTENTIAL; NECROSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROSTATE CANCER; WESTERN BLOTTING;

EID: 84885117753     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.122     Document Type: Article

References (47)

1. Baxter JD, Webb P. 2006. Metabolism: bile acids heat things up. Nature 439:402-403 DOI 10.1038/439402a.
2. Bourque SD, Titorenko VI. 2009. A quantitative assessment of the yeast lipidome using electrospray ionization mass spectrometry. Journal of Visualized Experiments 30:e1513 DOI 10.3791/1513.
3. Cabon L, Galan-Malo P, Bouharrour A, Delavallee L, Brunelle-Navas MN, Lorenzo HK, Gross A, Susin SA. 2012. BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation. Cell Death and Differentiation 19:245-256 DOI 10.1038/cdd.2011.91.
4. Cao X, Deng X, MayWS. 2003. Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood 102:2605-2614 DOI 10.1182/blood-2003-01-0211.
5. Chen X, Lou G, Meng Z, Huang W. 2011. TGR5: a novel target for weight maintenance and glucose metabolism. Experimental Diabetes Research 2011:853501.
6. Choi YH, ImEO, Suh H, Jin Y, Yoo YH, Kim ND. 2003. Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. Cancer Letters 199:157-167 DOI 10.1016/S0304-3835(03)00351-3.
7. Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M, Harmar AJ. 2005. International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacological Reviews 57:279-288 DOI 10.1124/pr.57.2.5.
8. Gao G, Dou QP. 2000. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. Journal of Cellular Biochemistry 80:53-72 DOI 10.1002/1097-4644(20010101)80:153::AID-JCB603.0.CO;2-E.
9. Giordano C, Catalano S, Panza S, Vizza D, Barone I, Bonofiglio D, Gelsomino L, Rizza P, Fuqua SAW, Andò S. 2011. Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression. Oncogene 30:4129-4140 DOI 10.1038/onc.2011.124.
10. Goldberg AA, Beach A, Davies GF, Harkness TA, Leblanc A, Titorenko VI. 2011. Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells. Oncotarget 2:761-782.
11. Goldberg AA, Richard VR, Kyryakov P, Bourque SD, Beach A, Burstein MT, Glebov A, Koupaki O, Boukh-Viner T, Gregg C, Juneau M, English AM, Thomas DY, Titorenko VI. 2010. Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner, by modulating housekeeping longevity assurance processes. Aging (Albany NY) 2:393-414.
12. Hageman J, Herrema H, Groen AK, Kuipers F. 2010. A role of the bile salt receptor FXR in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 30:1519-1528 DOI 10.1161/ATVBAHA.109.197897.
13. Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, Dent P. 2009. Bile acids as regulatory molecules. Journal of Lipid Research 50:1509-1520 DOI 10.1194/jlr. R900007-JLR200.
14. Katona BW, Anant S, Covey DF, Stenson WF. 2009. Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines. Journal of Biological Chemistry 284:3354-3564 DOI 10.1074/jbc. M805804200.
15. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y, Hinuma S, Fujisawa Y, Fujino M. 2003. A G protein-coupled receptor responsive to bile acids. Journal of Biological Chemistry 278:9435-9440 DOI 10.1074/jbc. M209706200.
16. Kim ND, ImE, Yoo YH, Choi YH. 2006. Modulation of the cell cycle and induction of apoptosis in human cancer cells by synthetic bile acids. Current Cancer Drug Targets 6:681-689 DOI 10.2174/156800906779010236.
17. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. 2009. Role of bile acids and bile acid receptors in metabolic regulation. Physiological Reviews 89:147-191 DOI 10.1152/physrev.00010.2008.
18. Lim SC, Duong HQ, Parajuli KR, Han SI. 2012. Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells. Oncology Reports 28:1429-1434.
19. Makadia HK, Siegel SJ. 2011. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 3:1377-1397 DOI 10.3390/polym3031377.
20. McLeod DG. 1997. Tolerability of nonsteroidal antiandrogens in the treatment of advanced prostate cancer. Oncologist 2:18-27.
21. Merrill RA, Dagda RK, Dickey AS, Cribbs JT, Green SH, Usachev YM, Strack S. 2011. Mechanism of neuroprotective mitochondrial remodeling by PKA/AKAP1. PLoS Biology 9:e1000612 DOI 10.1371/journal.pbio.1000612.
22. Moubarak RS, Yuste VJ, Artus C, Bouharrour A, Greer PA, Menissier-deMurcia J, Susin SA. 2007. Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Molecular and Cellular Biology 27:4844-4862 DOI 10.1128/MCB.02141-06.
23. Nunes AF, Amaral JD, Lo AC, Fonseca MB, Viana RJ, Callaerts-Vegh Z, D'Hooge R, Rodrigues CMP. 2012. TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-beta deposition in APP/PS1 mice. Molecular Neurobiology 45:440-454 DOI 10.1007/s12035-012-8256-y.
24. Peiro-Jordan R, Krishna-Subramanian S, Hanski ML, Luscher-FirzlaffJ, Zeitz M, Hanski C. 2012. The chemopreventive agent ursodeoxycholic acid inhibits proliferation of colon carcinoma cells by suppressing c-Myc expression. European Journal of Cancer Prevention 21:413-422 DOI 10.1097/CEJ.0b013e32834ef16f.
25. Pols TW, Noriega LG, Nomura M, Auwerx J, Schoonjans K. 2011. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. Journal of Hepatology 54:1263-1272 DOI 10.1016/j.jhep.2010.12.004.
26. Quispe-Tintaya W, Chandra D, Jahangir A, Harris M, Casadevall A, Dadachova E, Gravekamp C. 2013. Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 110(21):8668-8673 DOI 10.1073/pnas.1211287110.
27. Ramalho RM, Viana RJ, LowWC, Steer CJ, Rodrigues CM. 2008. Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease. Trends in Molecular Medicine 14:54-62 DOI 10.1016/j.molmed.2007.12.001.
28. Sato H, Macchiarulo A, Thomas C, Gioiello A, Une M, Hofmann AF, Saladin R, Schoonjans K, Pellicciari R, Auwerx J. 2008. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. Journal of Medicinal Chemistry 51:1831-1841 DOI 10.1021/jm7015864.
29. Schneider CA, RasbandWS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nature Methods 9:671-675 DOI 10.1038/nmeth.2089.
30. Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 62:10-29 DOI 10.3322/caac.20138.
31. Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, Gores GJ. 2000. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. American Journal of Psychology Gastrointest Liver Psychology 278:G992-G999.
32. Sola S, Castro RE, Laires PA, Steer CJ, Rodrigues CM. 2003. Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway. Molecular Medicine 9:226-234 DOI 10.2119/2003-00042.Rodrigues.
33. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M, Pellicciari R, Auwerxsend J, Schoonjans K. 2009. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metabolism 10:167-177 DOI 10.1016/j.cmet.2009.08.001.
34. Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. 2008. Targeting bile-acid signalling for metabolic diseases. Nature Reviews Drug Discovery 7:678-693 DOI 10.1038/nrd2619.
35. Tiwari A, Maiti P. 2009. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders. Drug Discovery Today 14:523-530 DOI 10.1016/j.drudis.2009.02.005.
36. Toyota H, Yanase N, Yoshimoto T, Moriyama M, Sudo T, Mizuguchi J. 2003. Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Letters 189:221-230 DOI 10.1016/S0304-3835(02)00552-9.
37. Trauner M, Claudel T, Fickert P, Moustafa T, Wagner M. 2010. Bile acids as regulators of hepatic lipid and glucose metabolism. Digestive Diseases 28:220-224 DOI 10.1159/000282091.
38. Vallim TQ, Edwards PA. 2009. Bile acids have the gall to function as hormones. Cell Metabolism 10:162-164 DOI 10.1016/j.cmet.2009.08.005.
39. Viana RJ, Nunes AF, Castro RE, Ramalho RM, Meyerson J, Fossati S, Ghiso J, Rostagno A, Rodrigues CMP. 2009. Tauroursodeoxycholic acid prevents E22Q Alzheimer's A toxicity in human cerebral endothelial cells. Cellular and Molecular Life Science 66:1094-1104 DOI 10.1007/s00018-009-8746-x.
40. Vogel SM, Bauer MR, Joerger AC, Wilcken R, Brandt T, Veprintsev DB, Rutherford TJ, Fersht AR, Boeckler FM. 2012. Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2. Proceedings of the National Academy of Sciences of the United States of America 109:16906-16910 DOI 10.1073/pnas.1215060109.
41. Wachs FP, Krieg RC, Rodrigues CM, Messmann H, Kullmann F, Knuchel-Clarke R, Schölmerich J, Rogler G, Schlottmann K. 2005. Bile salt-induced apoptosis in human colon cancer cell lines involves the mitochondrial transmembrane potential but not the CD95 (Fas/Apo-1) receptor. International Journal of Colorectal Disease 20:103-113 DOI 10.1007/s00384-004-0616-2.
42. Whiteman M, Chu SH, Siau JL, Rose P, Sabapathy K, Schantz J-T, Cheung NS, Spencer JPE, Armstrong JS. 2007. The pro-inflammatory oxidant hypochlorous acid induces Bax-dependent mitochondrial permeabilisation and cell death through AIF-/EndoG-dependent pathways. Cellular Signalling 19:705-714 DOI 10.1016/j.cellsig.2006.08.019.
43. Wood DE, Newcomb EW. 2000. Cleavage of Bax enhances its cell death function. Experimental Cell Research 256:375-382 DOI 10.1006/excr.2000.4859.
44. Wysowski DK, Freiman JP, Tourtelot JB, Horton ML III. 1993. Fatal and nonfatal hepatotoxicity associated with flutamide. Annals of Internal Medicine 118:860-864 DOI 10.7326/0003-4819-118-11-199306010-00006.
45. Yang H, Li TW, Ko KS, Xia M, Lu SC. 2009. Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes. Hepatology 49:860-870 DOI 10.1002/hep.22720.
46. Yang JI, Yoon JH, Myung SJ, Gwak GY, Kim W, Chung GE, Lee SH, Lee S-M, Kim CY, Lee H-S. 2007. Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes. Biochemical and Biophysical Research Communications 361:156-161 DOI 10.1016/j.bbrc.2007.07.001.
47. Zhong M. 2010. TGR5 as a therapeutic target for treating obesity. Current Topics in Medicinal Chemistry 10:386-396 DOI 10.2174/156802610790980576.